Paragon Biosciences Employee Directory
Biotechnology ResearchIllinois, United States11-50 Employees
Paragon Biosciences is a Chicago-based biotechnology organization that operates as a global life science platform, creating, developing, and funding biology-based companies to accelerate medical breakthroughs. The company focuses on biopharmaceuticals, cell and gene therapies, and synthetic biology, with the objective of delivering therapies for serious diseases with unmet needs. It operates on a relatively small scale and provides support to its ventures as they progress through development stages. In June 2026, Paragon announced the closing of the sale of Emalex Biosciences to Teva Pharmaceutical Industries Ltd. Emalex was established by Paragon in 2018 to develop treatments for central nervous system disorders, illustrating one facet of Paragon's historical focus in neurology-related therapies.